Business Description
RespireRx Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US7612272069
Description
RespireRx Pharmaceuticals Inc is engaged in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders. The pipeline products of the company are dronabinol which is developed for the treatment of OSA (Obstructive Sleep Apnea), a form of sleep apnea; CX1739 for the treatment of chronic central sleep apnea; CX717 and CX1942 is an injectable dosage for respiratory depression or vaso-occlusive passes associated with sickle cell disease. The company also focuses on developing another class of compounds called ampakines for the treatment of various respiratory disorders.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -112.81 | |||||
| Debt-to-Equity | -0.23 | |||||
| Debt-to-EBITDA | -2.04 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 85.6 | |||||
| 3-Year EPS without NRI Growth Rate | 80.4 | |||||
| 3-Year FCF Growth Rate | 90.7 | |||||
| 3-Year Book Growth Rate | 82.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.81 | |||||
| 9-Day RSI | 38.18 | |||||
| 14-Day RSI | 41.04 | |||||
| 6-1 Month Momentum % | -10 | |||||
| 12-1 Month Momentum % | -70 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.01 | |||||
| Quick Ratio | 0.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -570 | |||||
| Shareholder Yield % | -101.48 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -2.95 | |||||
| EV-to-EBITDA | -2.95 | |||||
| EV-to-FCF | -16.17 | |||||
| Earnings Yield (Greenblatt) % | -33.9 | |||||
| FCF Yield % | -65.61 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:RSPI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
RespireRx Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.025 | ||
| Beta | 0.92 | ||
| Volatility % | 207.07 | ||
| 14-Day RSI | 41.04 | ||
| 14-Day ATR ($) | 0.000151 | ||
| 20-Day SMA ($) | 0.000935 | ||
| 12-1 Month Momentum % | -70 | ||
| 52-Week Range ($) | 0.0006 - 0.0191 | ||
| Shares Outstanding (Mil) | 471.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
RespireRx Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
RespireRx Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
RespireRx Pharmaceuticals Inc Frequently Asked Questions
What is RespireRx Pharmaceuticals Inc(RSPI)'s stock price today?
The current price of RSPI is $0.00. The 52 week high of RSPI is $0.02 and 52 week low is $0.00.
When is next earnings date of RespireRx Pharmaceuticals Inc(RSPI)?
The next earnings date of RespireRx Pharmaceuticals Inc(RSPI) is .
Does RespireRx Pharmaceuticals Inc(RSPI) pay dividends? If so, how much?
RespireRx Pharmaceuticals Inc(RSPI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers